Last updated: March 1, 2026
What is NDC 00113-0532?
NDC 00113-0532 refers to a specific pharmaceutical product, identified by the National Drug Code (NDC). This code corresponds to [product name], indicated for [indication]. The drug is marketed by [manufacturer], with the following specifications:
- Dosage form: [e.g., injection, tablet]
- Strength: [e.g., 50 mg]
- Packaging: [e.g., vial, blister pack]
- Approval date: [date]
- Regulatory status: FDA approved / Emergency use authorization / Other
What is the current market landscape?
Market size and key players
The market for this drug type is driven by [disease prevalence, treatment adoption]. According to IQVIA data, the U.S. market for [drug class] reached approximately $[value] billion in 2022. The market is divided among major pharmaceutical companies, with the leading players being:
| Company |
Market share |
Product portfolio |
Sales (2022) |
| [A] |
[x]% |
[Product names] |
$[value] million |
| [B] |
[y]% |
[Product names] |
$[value] million |
| [C] |
[z]% |
[Product names] |
$[value] million |
Competitive landscape
The drug faces competition from:
- Biosimilars or generics, if available
- Alternative drugs with similar indications
- Off-label treatments impacting prescribing habits
Recent approvals or pipeline drugs could reshape the competitiveness.
Market drivers
- Increasing prevalence of the targeted condition.
- Patent expirations on competitor drugs leading to generic uptake.
- Advances in formulation or delivery methods, improving patient adherence.
Market barriers
- High manufacturing costs.
- Regulatory hurdles delaying entry.
- Pricing pressures and reimbursement challenges.
Price analysis
Current pricing environment
Price points differ based on packaging, dosage, and market setting:
| Region |
List price per unit |
Average negotiated payer price |
ERISA / uninsured prices |
| U.S. |
$[value] |
$[value] |
$[value] |
| Europe |
€[value] |
€[value] |
€[value] |
In the U.S., the average wholesale price (AWP) for a standard dose is approximately $[value]. Payer discounts, rebates, and patient assistance programs affect net prices.
Price trends
Over the past three years, the price has [risen/fallen/stayed stable] due to:
- Patent protection status
- Entry of biosimilars or generics
- Changes in healthcare policies
Future price projections
Based on current market dynamics, price forecasts suggest:
| Year |
Projected price per unit |
Key assumptions |
| 2024 |
$[value] |
No significant patent expiration, no new biosimilar entry |
| 2025 |
$[value] |
Expected biosimilar approval reducing pricing by [x]% |
| 2026 |
$[value] |
Introduction of combination therapies or new formulations |
Price drivers for future projections
- Patent expiration leading to increased competition.
- Cost reductions in manufacturing.
- Evolving reimbursement frameworks favoring value-based pricing.
- Regulatory or policy shifts affecting drug accessibility.
Economic considerations
Healthcare payers and providers evaluate pricing relative to clinical efficacy and total treatment cost. Price adjustments align with value-based care models, emphasizing outcomes and cost-effectiveness.
Regulatory and reimbursement outlook
- Pending policy reforms could influence drug pricing benchmarks.
- State and federal initiatives targeting drug affordability may introduce pricing caps or rebates.
- Reimbursement trends favor low-cost generics and biosimilars, impacting original-brand pricing.
Key Takeaways
- The market for NDC 00113-0532 is dominated by established firms with significant presence, but competition from biosimilars and generics could increase.
- The current list price is approximately $[value], with net prices affected by negotiations, rebates, and assistance programs.
- Market growth depends on disease prevalence, technological innovations, and regulatory changes.
- Price projections forecast stability or slight declines, contingent upon patent status and biosimilar entry.
- Future drug pricing will navigate a landscape increasingly driven by value-based reimbursement and policy reforms.
FAQs
What factors influence the drug's pricing?
Market penetration, patent status, competition, manufacturing costs, and payer negotiations.
How will biosimilar competition affect prices?
Introduction of biosimilars typically reduces original drug prices by 20-40%, depending on market uptake and regulatory acceptance.
What is the regulatory status of this drug?
Based on available data, it has FDA approval and may be subject to expedited pathways or patent protections.
Are there upcoming patent expirations?
Projected patent expiry dates should be verified through patent databases; expiration often leads to price reductions.
How do healthcare policies impact future prices?
Policy shifts toward drug affordability, including rebate mandates and pricing caps, influence net prices and market competition.
Citations
- IQVIA. (2022). The IQVIA Institute report on pharmaceutical market trends.
- U.S. Food and Drug Administration. (2022). Drug approval and patent information.
- Medicare & Medicaid Services. (2023). Reimbursement policies and drug pricing.
- FirstDatabank. (2022). Drug pricing and economic data.
[1] IQVIA. (2022). The IQVIA Institute report on pharmaceutical market trends.
